Upcoming Investor Conference Presentations, Donations and Acquisitions - Research Report on Jazz Pharmaceuticals, DENTSPLY,

   Upcoming Investor Conference Presentations, Donations and Acquisitions -
Research Report on Jazz Pharmaceuticals, DENTSPLY, Teleflex, DexCom, and Cell
                                 Therapeutics

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

NEW YORK, November 28, 2013

NEW YORK, November 28, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Jazz
Pharmaceuticals plc (NASDAQ: JAZZ), DENTSPLY International Inc. (NASDAQ:
XRAY), Teleflex Incorporated (NYSE: TFX), DexCom, Inc. (NASDAQ: DXCM), and
Cell Therapeutics, Inc. (NASDAQ: CTIC). Today's readers may access these
reports free of charge - including full price targets, industry analysis and
analyst ratings - via the links below.

Jazz Pharmaceuticals plc Research Report 

On November 20, 2013, Jazz Pharmaceuticals plc (Jazz Pharmaceuticals)
announced that the Company will webcast its participation at the 25th Annual
Piper Jaffray Healthcare Conference in New York, NY. According to the Company,
Bruce C. Cozadd, Chairman and CEO of Jazz Pharmaceuticals, will present a
corporate overview at the aforesaid conference on Tuesday, December 3, 2013 at
8:30 a.m. EST or 1:30 p.m. GMT. The Company informed that a live audio webcast
of the presentation may also be accessed from the Investors section of the
Jazz Pharmaceuticals' website. The Full Research Report on Jazz
Pharmaceuticals plc - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/5fe3_JAZZ

--

DENTSPLY International Inc. Research Report

On November 22, 2013, DENTSPLY International Inc. (DENTSPLY) announced that it
has completed the acquisition of QAHR, a direct dental selling organization
with its headquarters in Hong Kong and operations in mainland China. The
Company informed that it has also entered into an agreement to acquire certain
assets of Triodent, a New Zealand-based manufacturer of a line of professional
dental consumables used in restorative dentistry. According to the Company,
the two aforesaid acquisitions represent aggregate annual revenue of c.$30
million, of which approximately half would be incremental to DENTSPLY given
the prior commercial relationship that existed with both the Companies. The
Full Research Report on DENTSPLY International Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

http://www.analystscorner.com/r/full_research_report/6b01_XRAY

--

Teleflex Incorporated Research Report

On November 21, 2013, Teleflex Incorporated (Teleflex) announced an initial
donation of $25,000 in support of disaster relief efforts in the Philippines.
Teleflex informed that it is also organizing its global workforce to support
the cause with donations which will be matched by the Teleflex Foundation.
According to the Company, Teleflex has identified the American Red Cross for
its corporate grant, and it is also matching gifts of employees to other
disaster relief agencies, while individual donations and group collections are
taking place at Teleflex workplaces globally. "Our purpose as a company is to
improve the health and quality of peoples' lives," said Benson Smith,
Chairman, President and CEO of Teleflex. "We feel a deep responsibility to be
part of the effort to support the people of the Philippines as they recover
from this tragedy, and we are challenging our employees to give whatever they
can to this effort by committing an equal match from the company." The Full
Research Report on Teleflex Incorporated - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at: 

http://www.analystscorner.com/r/full_research_report/9c7d_TFX

--

DexCom, Inc. Research Report 

On November 21, 2013, DexCom, Inc. (DexCom) announced that its CEO Terry Gregg
will present an update on the Company at the 25th Annual Piper Jaffray
Healthcare Conference in New York, on Tuesday, December 3, 2013 at 11:30 a.m.
EST. Additionally, the Company informed about its upcoming presentation at the
Oppenheimer 24th Annual Healthcare Conference in New York, wherein Steve
Pacelli, EVP, Strategy and Corporate Development, will provide an update on
the Company on Tuesday, December 10, 2013 at 10:20 a.m. EST. The Full Research
Report on DexCom, Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/d377_DXCM

--

Cell Therapeutics, Inc. Research Report

On November 18, 2013, Cell Therapeutics, Inc. (Cell Therapeutics) announced
that the Company's management will present at the Piper Jaffray 25th Annual
Healthcare Conference on December 4, 2013, at 8:50 a.m. EST, to be held in New
York, NY. According to the Company, a live webcast of the presentation will be
available along with a replay version at Cell Therapeutics' website. The Full
Research Report on Cell Therapeutics, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

http://www.analystscorner.com/r/full_research_report/f9df_CTIC

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

AnalystsCorner.com

SOURCE Analysts' Corner

Contact: Joe Thomas CONTACT PHONE: +1-310-496-8071 (North America)
 
Press spacebar to pause and continue. Press esc to stop.